ASN
INSY

Advisory Services Network’s Insys Therapeutics, Inc. INSY Stock Holding History

Advisory Services Network’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4K Buy
+350
New +$5.32K ﹤0.01% 1639

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Advisory Services Network's INSY Position: Q3 2016 in Review

Advisory Services Network opened a new position in Insys Therapeutics, Inc. (INSY) in Q3 2016: 350 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #1639 among its holdings.

138 funds tracked by Wall St. Rank hold INSY as of Q3 2016.

  • Advisory Services Network held 350 shares of Insys Therapeutics, Inc. worth $4K as of Q3 2016.
  • Insys Therapeutics, Inc. was a new Advisory Services Network position in Q3 2016.
  • Insys Therapeutics, Inc. made up ﹤0.01% of Advisory Services Network's portfolio in Q3 2016, its #1639 holding.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2016.

Based on Advisory Services Network's 13F filing for Q3 2016, filed 7 Oct 2016.